Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/8/25 16:10 | 1/8/25 | LFCR | Health | Drug | Pharmaceutical Preparations | Josephs Paul | MN | DO | CEO | 1 | P | 98 | 5.74 | 0 | 17 | 3 | 560 | D | ||||||||||||||
10/7/24 20:45 | 10/3/24 | LFCR | Health | Drug | Pharmaceutical Preparations | Wynnefield Partners Small Cap Value LP I | NY | T | 1 | P | 1,200 | 4.10 | 0 | 293 | 7 | 4,703 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |